药物洗脱支架经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干冠状动脉疾病的个体患者数据荟萃分析
该个体患者数据荟萃分析纳入4项RCT(SYNTAX、PRECOMBAT、NOBLE、EXCEL),共4394例左主干冠状动脉疾病患者,随机接受PCI(药物洗脱支架,n=2197)或CABG(n=2197),中位SYNTAX评分25.0(IQR 18.0-31.0)。5年全因死亡PCI为11.2%(95%CI 9.9-12.6),CABG为10.2%(9.0-11.6),HR 1.10(95%CI 0.91-1.32;p=0.33),绝对风险差0.9%(95%CI -0.9至2.8),无统计学显著差异;贝叶斯分析显示PCI 5年死亡大于CABG的概率为85.7%,差异更可能小于1.0%(每年<0.2%)。PCI组自发性心肌梗死(HR 2.35,95%CI 1.71-3.23;p<0.0001)和再次血运重建(HR 1.78,95%CI 1.51-2.10;p<0.0001)更多,卒中总体无差异(HR 0.84,95%CI 0.59-1.21;p=0.36),但随机化后第一年PCI卒中风险更低(HR 0.37,95%CI 0.19-0.69)。作者认为,心脏团队沟通预期结局差异可能有助于患者决策。
要点
- 左主干病变患者5年全因死亡PCI 11.2% vs CABG 10.2%,HR 1.10(95%CI 0.91-1.32;p=0.33),无统计学显著差异。
- 贝叶斯分析:PCI 5年死亡大于CABG的概率85.7%,差异更可能小于1.0%(每年<0.2%),倾向于CABG。
- PCI组自发性心肌梗死更多:6.2% vs 2.6%,HR 2.35(95%CI 1.71-3.23;p<0.0001)。
- PCI组再次血运重建更多:18.3% vs 10.7%,HR 1.78(95%CI 1.51-2.10;p<0.0001)。
- 卒中总体无差异(PCI 2.7% vs CABG 3.1%,HR 0.84,95%CI 0.59-1.21;p=0.36),但随机化后第一年PCI卒中风险更低(HR 0.37,95%CI 0.19-0.69)。
适用人群与场景
- 左主干冠状动脉疾病患者,纳入4项RCT(SYNTAX、PRECOMBAT、NOBLE、EXCEL),中位SYNTAX评分25.0(IQR 18.0-31.0),冠状动脉解剖复杂度多为低或中等。
研究设计与关键结果
- 研究类型:个体患者数据荟萃分析,纳入4项RCT(SYNTAX、PRECOMBAT、NOBLE、EXCEL),共4394例患者随机接受PCI(n=2197)或CABG(n=2197),中位SYNTAX评分25.0(IQR 18.0-31.0)。
- 主要终点5年全因死亡:PCI 11.2%(95%CI 9.9-12.6)vs CABG 10.2%(95%CI 9.0-11.6),HR 1.10(95%CI 0.91-1.32;p=0.33),绝对风险差0.9%(95%CI -0.9至2.8),无统计学显著差异。
- 贝叶斯分析:PCI 5年死亡大于CABG的概率为85.7%;差异更可能小于1.0%(每年<0.2%)。
- 自发性心肌梗死:PCI 6.2%(95%CI 5.2-7.3)vs CABG 2.6%(95%CI 2.0-3.4),HR 2.35(95%CI 1.71-3.23;p<0.0001)。
- 再次血运重建:PCI 18.3%(95%CI 16.7-20.0)vs CABG 10.7%(95%CI 9.4-12.1),HR 1.78(95%CI 1.51-2.10;p<0.0001)。
- 卒中总体:PCI 2.7%(95%CI 2.0-3.5)vs CABG 3.1%(95%CI 2.4-3.9),HR 0.84(95%CI 0.59-1.21;p=0.36);随机化后第一年PCI卒中风险更低(HR 0.37,95%CI 0.19-0.69)。
- 围术期心肌梗死差异取决于所用定义。
证据类型、等级与局限
- 证据类型:个体患者数据荟萃分析,纳入4项随机对照试验(SYNTAX、PRECOMBAT、NOBLE、EXCEL)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,心脏团队沟通预期结局差异可能有助于患者做出治疗决策。
- 对于左主干冠状动脉疾病且解剖复杂度多为低或中等者,PCI与CABG的5年全因死亡无统计学显著差异,但贝叶斯分析提示CABG可能略优(每年<0.2%);两者在心肌梗死、卒中和再次血运重建风险上存在权衡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The optimal revascularisation strategy for patients with left main coronary artery disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated with percutaneous coronary intervention (PCI) with drug-eluting stents versus coronary artery bypass grafting (CABG).
METHODS: In this individual patient data meta-analysis, we searched MEDLINE, Embase, and the Cochrane database using the search terms "left main", "percutaneous coronary intervention" or "stent", and "coronary artery bypass graft*" to identify randomised controlled trials (RCTs) published in English between database inception and Aug 31, 2021, comparing PCI with drug-eluting stents with CABG in patients with left main coronary artery disease that had at least 5 years of patient follow-up for all-cause mortality. Two authors (MSS and BAB) identified studies meeting the criteria. The primary endpoint was 5-year all-cause mortality. Secondary endpoints were cardiovascular death, spontaneous myocardial infarction, procedural myocardial infarction, stroke, and repeat revascularisation. We used a one-stage approach; event rates were calculated by use of the Kaplan-Meier method and treatment group comparisons were made by use of a Cox frailty model, with trial as a random effect. In Bayesian analyses, the probabilities of absolute risk differences in the primary endpoint between PCI and CABG being more than 0·0%, and at least 1·0%, 2·5%, or 5·0%, were calculated.
FINDINGS: Our literature search yielded 1599 results, of which four RCTs-SYNTAX, PRECOMBAT, NOBLE, and EXCEL-meeting our inclusion criteria were included in our meta-analysis. 4394 patients, with a median SYNTAX score of 25·0 (IQR 18·0-31·0), were randomly assigned to PCI (n=2197) or CABG (n=2197). The Kaplan-Meier estimate of 5-year all-cause death was 11·2% (95% CI 9·9-12·6) with PCI and 10·2% (9·0-11·6) with CABG (hazard ratio 1·10, 95% CI 0·91-1·32; p=0·33), resulting in a non-statistically significant absolute risk difference of 0·9% (95% CI -0·9 to 2·8). In Bayesian analyses, there was an 85·7% probability that death at 5 years was greater with PCI than with CABG; this difference was more likely than not less than 1·0% (<0·2% per year). The numerical difference in mortality was comprised more of non-cardiovascular than cardiovascular death. Spontaneous myocardial infarction (6·2%, 95% CI 5·2-7·3 vs 2·6%, 2·0-3·4; hazard ratio [HR] 2·35, 95% CI 1·71-3·23; p<0·0001) and repeat revascularisation (18·3%, 16·7-20·0 vs 10·7%, 9·4-12·1; HR 1·78, 1·51-2·10; p<0·0001) were more common with PCI than with CABG. Differences in procedural myocardial infarction between strategies depended on the definition used. Overall, there was no difference in the risk of stroke between PCI (2·7%, 2·0-3·5) and CABG (3·1%, 2·4-3·9; HR 0·84, 0·59-1·21; p=0·36), but the risk was lower with PCI in the first year after randomisation (HR 0·37, 0·19-0·69).
INTERPRETATION: Among patients with left main coronary artery disease and, largely, low or intermediate coronary anatomical complexity, there was no statistically significant difference in 5-year all-cause death between PCI and CABG, although a Bayesian approach suggested a difference probably exists (more likely than not <0·2% per year) favouring CABG. There were trade-offs in terms of the risk of myocardial infarction, stroke, and revascularisation. A heart team approach to communicate expected outcome differences might be useful to assist patients in reaching a treatment decision.
FUNDING: No external funding.
参考来源
- Sabatine MS, Bergmark BA, Murphy SA, et al. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis. Lancet. 2021. PMID: 34793745. doi:10.1016/S0140-6736(21)02334-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。